← Eichor
Condition: Neonatal Thrombocytopenia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Neonatal Thrombocytopenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Phase N/A · 2 location(s) · Boston Children's Hospital · NCT03848923Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
Phase 2 · 1 location(s) · Medical University of Vienna · NCT07273721Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Phase N/A · 8 location(s) · Karolinska Institutet · NCT04598750Neonatal Platelet Transfusion Threshold Trial
NA · 20 location(s) · NICHD Neonatal Research Network · NCT06676904Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
NA · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT05996731Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852GROWing Up With Rare GENEtic Syndromes
Phase N/A · 1 location(s) · dr. Laura C. G. de Graaff-Herder · NCT04463316A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · 21 location(s) · Janssen Research & Development, LLC · NCT06449651A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thro
Phase 3 · 26 location(s) · Janssen Research & Development, LLC · NCT06533098Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06794008Investigation of the Genetics of Hematologic Diseases
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT02720679
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.